R. S. Burns

Clinical presentation and pharmacological therapy in cortico-basal ganglionic degeneration

Kailash P. Bhatia, C. D. Marsden, Christopher G. Goetz, 1996 .

Levels ofpros-methylimidazoleacetic acid: Correlation with severity of Parkinson's disease in CSF of patients and with the depletion of striatal dopamine and its metabolites in MPTP-treated mice

R. S. Burns, J. Green, P. Blandina, 1991, Journal of neural transmission. Parkinson's disease and dementia section.

Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism

R. S. Burns, M. Herkenham, S. Markey, 1984, Nature.